. 2015 Aug 24;5(5):442–453. doi: 10.1016/j.apsb.2015.07.003
© 2015 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1.
Benefits of insoluble drug delivery strategies.